BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22576629)

  • 21. Apolipoprotein A5 gene variants are associated with decreased adiponectin levels and increased arterial stiffness in subjects with low high-density lipoprotein-cholesterol levels.
    Kim M; Kim M; Yoo HJ; Bang YJ; Lee SH; Lee JH
    Clin Genet; 2018 Nov; 94(5):438-444. PubMed ID: 30132804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis.
    Guardiola M; Cofán M; de Castro-Oros I; Cenarro A; Plana N; Talmud PJ; Masana L; Ros E; Civeira F; Ribalta J
    Atherosclerosis; 2015 May; 240(1):98-104. PubMed ID: 25770687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of genetic risk for metabolic syndrome.
    Yamada Y; Kato K; Hibino T; Yokoi K; Matsuo H; Segawa T; Watanabe S; Ichihara S; Yoshida H; Satoh K; Nozawa Y
    Atherosclerosis; 2007 Apr; 191(2):298-304. PubMed ID: 16806226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol, Carbohydrate, and Calcium Intakes and Smoking Interactions with APOA5 rs662799 and rs2266788 were Associated with Elevated Plasma Triglyceride Concentrations in a Cross-Sectional Study of Korean Adults.
    Park S; Kang S
    J Acad Nutr Diet; 2020 Aug; 120(8):1318-1329.e1. PubMed ID: 32335043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese - a cross-sectional data from the J-MICC Study.
    Hishida A; Morita E; Naito M; Okada R; Wakai K; Matsuo K; Nakamura K; Takashima N; Suzuki S; Takezaki T; Mikami H; Ohnaka K; Watanabe Y; Uemura H; Kubo M; Tanaka H; Hamajima N
    Endocr J; 2012; 59(7):589-99. PubMed ID: 22517333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between polymorphisms in MTHFR and APOA5 and metabolic syndrome in the Greek population.
    Vasilopoulos Y; Sarafidou T; Bagiatis V; Skriapa L; Goutzelas Y; Pervanidou P; Lazopoulou N; Chrousos GP; Mamuris Z
    Genet Test Mol Biomarkers; 2011 Sep; 15(9):613-7. PubMed ID: 21473680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents.
    Brito DD; Fernandes AP; Gomes KB; Coelho FF; Cruz NG; Sabino AP; Cardoso JE; Figueiredo-Filho PP; Diamante R; Norton CR; Sousa MO
    Mol Biol Rep; 2011 Oct; 38(7):4381-8. PubMed ID: 21132386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of genetic risk for dyslipidemia.
    Yamada Y; Matsuo H; Warita S; Watanabe S; Kato K; Oguri M; Yokoi K; Metoki N; Yoshida H; Satoh K; Ichihara S; Aoyagi Y; Yasunaga A; Park H; Tanaka M; Nozawa Y
    Genomics; 2007 Nov; 90(5):551-8. PubMed ID: 17919884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
    Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
    Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of a polymorphism of BTN2A1 with type 2 diabetes mellitus in Japanese individuals.
    Hiramatsu M; Oguri M; Kato K; Yoshida T; Fujimaki T; Horibe H; Yokoi K; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Yoshida H; Shinkai S; Nozawa Y; Murohara T; Yamada Y
    Diabet Med; 2011 Nov; 28(11):1381-7. PubMed ID: 21672009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of genetic variants with dyslipidemia.
    Abe S; Tokoro F; Matsuoka R; Arai M; Noda T; Watanabe S; Horibe H; Fujimaki T; Oguri M; Kato K; Minatoguchi S; Yamada Y
    Mol Med Rep; 2015 Oct; 12(4):5429-36. PubMed ID: 26238946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
    Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
    PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of a genetic variant of BTN2A1 with chronic kidney disease in Japanese individuals.
    Yoshida T; Kato K; Horibe H; Oguri M; Fukuda M; Satoh K; Aoyagi Y; Shinkai S; Nozawa Y; Yamada Y
    Nephrology (Carlton); 2011 Sep; 16(7):642-8. PubMed ID: 21557786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of apolipoprotein A1 and A5 polymorphisms with stroke subtypes in Han Chinese people in Taiwan.
    Hsu LC; Hsu LS; Lee TH
    Gene; 2019 Feb; 684():76-81. PubMed ID: 30367981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of a polymorphism of BTN2A1 with hypertension in Japanese individuals.
    Horibe H; Kato K; Oguri M; Yoshida T; Fujimaki T; Kawamiya T; Yokoi K; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Yoshida H; Shinkai S; Nozawa Y; Murohara T; Yamada Y
    Am J Hypertens; 2011 Aug; 24(8):924-9. PubMed ID: 21525964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren.
    Endo K; Yanagi H; Araki J; Hirano C; Yamakawa-Kobayashi K; Tomura S
    Hum Genet; 2002 Dec; 111(6):570-2. PubMed ID: 12436249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of APOA5 -1131T>C polymorphism and serum lipid levels in patients with type 2 diabetes.
    Celap I; Simundic AM; Nikolac N; Kackov S; Katalinic D
    DNA Cell Biol; 2013 Oct; 32(10):589-93. PubMed ID: 23919616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes.
    Cabré A; Lázaro I; Girona J; Manzanares JM; Marimón F; Plana N; Guardiola M; Heras M; Masana L
    Nutr Metab Cardiovasc Dis; 2010 May; 20(4):243-8. PubMed ID: 19765959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.